Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Therapeutic targeting of small molecule glues against RAS signalling-induced cancer
EF 2023-24
Résumé
Cells are the building blocks of life, and unsurprisingly, humans. Their growth is tightly regulated by complex signalling pathways that instruct them when to “go” and when to “stop.” Uncontrolled signalling where cells no longer know when to “stop” is an inevitable consequence of cancer. Some human cancers are especially hard to eliminate with the current availability of approved medications.
RAS is one of the signalling pathways that, when uncontrolled, is responsible for about one third of all human cancers. Normally, to relay a growth signal, different proteins need to interact with one another. In the RAS signalling pathway, the RAS protein’s interaction with the RAF protein is the “go” instruction for cell growth. In cancer cells, the RAS protein always gives this “go” instruction and keeps on interacting with RAF, thus causing uncontrolled cell growth. Our lab has found small molecule “glues” that can attach another protein called p120 to the RAF protein. We therefore expect p120 to act as the “stop” signal that blocks the interaction between RAS and RAF. My project will characterize the identity of these “glues,” and I hope to answer the following questions: which “glue” is the stickiest to both the p120 and RAF protein, and on which surfaces of the proteins do these “glues” stick to? Following that, if one were to take in this “glue” as a medication to treat cancer, I will also engineer it to minimize its toxicity to the human body. Overall, this “glue” can be developed into a novel and revolutionary strategy to treat previously hard-to-tackle cancers.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
525530
Name
Yu Jiacheng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Therapeutic targeting of small molecule glues against RAS signalling-induced cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chemical Structure; Crystallography; Drug Discovery; Molecules; Noncovalent Interactions
Abstract
Cells are the building blocks of life, and unsurprisingly, humans. Their growth is tightly regulated by complex signalling pathways that instruct them when to “go” and when to “stop.” Uncontrolled signalling where cells no longer know when to “stop” is an inevitable consequence of cancer. Some human cancers are especially hard to eliminate with the current availability of approved medications.
RAS is one of the signalling pathways that, when uncontrolled, is responsible for about one third of all human cancers. Normally, to relay a growth signal, different proteins need to interact with one another. In the RAS signalling pathway, the RAS protein’s interaction with the RAF protein is the “go” instruction for cell growth. In cancer cells, the RAS protein always gives this “go” instruction and keeps on interacting with RAF, thus causing uncontrolled cell growth. Our lab has found small molecule “glues” that can attach another protein called p120 to the RAF protein. We therefore expect p120 to act as the “stop” signal that blocks the interaction between RAS and RAF. My project will characterize the identity of these “glues,” and I hope to answer the following questions: which “glue” is the stickiest to both the p120 and RAF protein, and on which surfaces of the proteins do these “glues” stick to? Following that, if one were to take in this “glue” as a medication to treat cancer, I will also engineer it to minimize its toxicity to the human body. Overall, this “glue” can be developed into a novel and revolutionary strategy to treat previously hard-to-tackle cancers.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yu, Jiacheng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~